Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, FL, U.S.A.
Clin Sci (Lond). 2023 Sep 27;137(18):1451-1476. doi: 10.1042/CS20220314.
Resolution of edema remains a significant clinical challenge. Conditions such as traumatic shock, sepsis, or diabetes often involve microvascular hyperpermeability, which leads to tissue and organ dysfunction. Lymphatic insufficiency due to genetic causes, surgical removal of lymph nodes, or infections, leads to varying degrees of tissue swelling that impair mobility and immune defenses. Treatment options are limited to management of edema as there are no specific therapeutics that have demonstrated significant success for ameliorating microvascular leakage or impaired lymphatic function. This review examines current knowledge about the physiological, cellular, and molecular mechanisms that control microvascular permeability and lymphatic clearance, the respective processes for interstitial fluid formation and removal. Clinical conditions featuring edema, along with potential future directions are discussed.
水肿的消退仍然是一个重大的临床挑战。创伤性休克、败血症或糖尿病等病症常涉及微血管通透性增加,从而导致组织和器官功能障碍。由于遗传原因、淋巴结切除手术或感染导致的淋巴功能不足,会导致不同程度的组织肿胀,从而影响活动能力和免疫防御能力。治疗选择仅限于对水肿的管理,因为目前尚无特定的治疗方法能够显著成功地改善微血管渗漏或受损的淋巴功能。本文综述了目前关于控制微血管通透性和淋巴清除的生理、细胞和分子机制的知识,以及间质液形成和清除的相应过程。本文还讨论了伴有水肿的临床病症以及潜在的未来方向。